Lipella Pharmaceuticals Inc.
LIPO
$2.52
-$0.005-0.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.44M | -1.44M | -938.10K | -1.19M | -688.90K |
| Total Depreciation and Amortization | 700.00 | 700.00 | 1.40K | 100.00 | 700.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 80.70K | 379.40K | 80.00K | 409.30K | 0.00 |
| Change in Net Operating Assets | 369.90K | 411.40K | -62.00K | -606.00K | -39.50K |
| Cash from Operations | -990.40K | -653.10K | -918.80K | -1.39M | -727.70K |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 1.82M | 820.30K | 0.00 | 200.00K | 1.61M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.82M | 820.30K | 0.00 | 200.00K | 1.61M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | -- | -- |
| Net Change in Cash | 831.10K | 167.20K | -918.80K | -1.19M | 883.90K |